“…Recent findings in our laboratory have shown that both shortterm high-dose and long-term low-dose Cr(VI) exposure disrupt the inducible transcriptional response to B[a]P in Hepa-1 cells (Fan et al, 2012;Ovesen et al, 2014a;Wei et al, 2004). To determine whether these finding would also apply in vivo, we measure gene expression patterns in PSI, DSI, and liver of a battery of known or suspected B[a]P-target genes, including genes involved in drug metabolism (Cyp1a1 and Cyp1b1), oxidative stress (Hmox1, Nrf2, Gclc, Gclm, Gpx1, Gpx4, Gstp1, Gsta4, and Gstm5), tumor suppression (Cdkn1a/p21, Cdkn1b/p27, Cdkn2a/p16, Cdkn2b/p15, Cdkn2c/p18, Cdkn2c/p19, Hras, and P73), and inflammation (Tnfa and Il6).…”